MARKET

PRQR

PRQR

Proqr Therapeuti
NASDAQ
1.880
-0.005
-0.27%
After Hours: 1.890 +0.01 +0.53% 17:35 07/26 EDT
OPEN
1.900
PREV CLOSE
1.885
HIGH
1.920
LOW
1.870
VOLUME
19.96K
TURNOVER
0
52 WEEK HIGH
3.290
52 WEEK LOW
1.110
MARKET CAP
153.52M
P/E (TTM)
-5.2676
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PRQR last week (0715-0719)?
Weekly Report · 4d ago
Weekly Report: what happened at PRQR last week (0708-0712)?
Weekly Report · 07/15 11:50
Weekly Report: what happened at PRQR last week (0701-0705)?
Weekly Report · 07/08 11:52
Weekly Report: what happened at PRQR last week (0624-0628)?
Weekly Report · 07/01 11:52
Regenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock?
NASDAQ · 06/25 08:32
Weekly Report: what happened at PRQR last week (0617-0621)?
Weekly Report · 06/24 12:02
ProQR Presents Its Axiomer RNA Editing Technology At RNA Editing Summit
ProQR Therapeutics will participate in the RNA Editing Summit, June 18-20, 2024, in Boston, Massachusetts. ProQR is a company dedicated to changing lives through transformative RNA therapies. Gerard Platenburg will present on June 20, 2024 at 2:00pm.
Benzinga · 06/18 12:20
Weekly Report: what happened at PRQR last week (0610-0614)?
Weekly Report · 06/17 11:51
More
About PRQR
ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).

Webull offers ProQR Therapeutics NV stock information, including NASDAQ: PRQR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRQR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRQR stock methods without spending real money on the virtual paper trading platform.